SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya

• Hauptverfasser: Shradha Doshi (VerfasserIn), Hanley Kingston (VerfasserIn), Ashley S. Tseng (VerfasserIn), Bhavna H. Chohan (VerfasserIn), Betsy Sambai (VerfasserIn), Brandon L. Guthrie (VerfasserIn), Aliza Monroe-Wise (VerfasserIn), Loice W. Mbogo (VerfasserIn), Sarah Masyuko (VerfasserIn), Khai Hoan Tram (VerfasserIn), William Sinkele (VerfasserIn), Paul Macharia (VerfasserIn), David Bukusi (VerfasserIn), Joshua T. Herbeck (VerfasserIn), Carey Farquhar (VerfasserIn)
• Format: Buch
• Veröffentlicht: BMC, 2023-02-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background In sub-Saharan Africa many people who inject drugs (PWID) are living with undiagnosed or untreated HIV and experience high levels of poverty and conditions that can contribute to worse outcomes from SARS-CoV-2 infection. Identifying the burden of SARS-CoV-2 infection in marginali...